In terms of market side, this report researches the Lung Cancer Liquid Biopsy revenue, growth rate, market share by manufacturers, by type, by application and by region (region level and country level), from 2018 to 2023, and forecast to 2029.

The global Lung Cancer Liquid Biopsy market size in 2022 is 300.0 million US dollars, and it is expected to be XX million US dollars by 2029, with a compound annual growth rate of 21.00% expected in 2023-2029.

MARKET COMPETITIVE LANDSCAPE:

The main players in the Lung Cancer Liquid Biopsy market include Eurofins Scientific (Luxembourg), MDxHealth (Belgium), CareDx (U.S.), Immucor (U.S.), and Thermo Fisher Scientific Inc. (U.S.). The share of the top 3 players in the Lung Cancer Liquid Biopsy market is XX%.

REGION SHARE:

The report covers the market size information of North America, Europe, Asia Pacific, Latin America, Middle East and Africa, and North America accounted for XX%, Europe accounted for XX% of Lung Cancer Liquid Biopsy market, and Asia Pacific accounted for XX%.

SEGMENT OVERVIEW:

The report segments the market by Type and Application. CTC (Circulating Tumor Cells) accounted for XX% of Lung Cancer Liquid Biopsy market in 2022. ctDNA (Circulating tumor DNA) share of XX%.

Small Cell Lung Cancer accounted for XX% of the Lung Cancer Liquid Biopsy market in 2022. Non-Small Cell Lung Cancer accounts for XX%.

Report Includes:

This report presents an overview of global market for Lung Cancer Liquid Biopsy. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.

This report researches the key players of Lung Cancer Liquid Biopsy, also provides the consumption of main regions and countries. Highlights of the upcoming market potential for Lung Cancer Liquid Biopsy, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Lung Cancer Liquid Biopsy market share and industry ranking of main players, data from 2018 to 2023. Identification of the major stakeholders in the global Lung Cancer Liquid Biopsy market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, from 2018 to 2029. Evaluation and forecast the market size for Lung Cancer Liquid Biopsy sales, projected growth trends, technology, application and end-user industry.

The life sciences industry grows and continues to advance, driving innovation and improving healthcare outcomes for individuals around the world.

Artificial Intelligence (AI) and Machine Learning (ML): AI and ML technologies are increasingly being employed in life sciences research and development. They aid in drug discovery, optimizing clinical trials, analyzing vast amounts of biological data, and identifying patterns that can lead to breakthroughs in understanding diseases and developing new therapies.

Digital Health Technologies: Digital health technologies have seen rapid growth, especially in areas like telemedicine, wearable devices, and mobile health applications. These technologies enable remote patient monitoring, facilitate better healthcare access, and empower individuals to manage their health more effectively.

Wearable Devices and Remote Monitoring: Wearable devices, such as smartwatches and fitness trackers, have become more sophisticated, enabling continuous monitoring of vital signs and health parameters. These devices offer opportunities for early detection of health issues and improved management of chronic conditions.

Highlights-Regions

North America

United States

Canada

China

Asia Pacific (Excluding China)

Japan

Korea

Southeast Asia

India

Australia

EMEA

Europe

Germany

France

UK

Italy

Russia

Nordic

Middle East

Africa

Latin America

Brazil

Argentina

Mexico

Player list

Eurofins Scientific (Luxembourg)

MDxHealth (Belgium)

CareDx (U.S.)

Immucor (U.S.)

Thermo Fisher Scientific Inc. (U.S.)

Menarini Silicon Biosystems (U.S.)

QIAGEN (Germany)

Guardant Health (U.S.)

Exact Sciences Corporation (U.S.)

Myriad Genetics, Inc. (U.S.)

LungLife AI, Inc. (U.S.)

Bio-Rad Laboratories, Inc. (U.S.)

Agilent Technologies Inc. (U.S.)

Natera, Inc. (U.S.)

CARDIFF ONCOLOGY, INC. (U.S.)

Exosome Diagnostics Inc. (U.S.)

Illumina, Inc. (U.S.)

Genomic Health Inc. (U.S.)

F. Hoffmann-La Roche Ltd (Switzerland)

Types list

CTC (Circulating Tumor Cells)

ctDNA (Circulating tumor DNA)

Exosomes and RNA

Application list

Small Cell Lung Cancer

Non-Small Cell Lung Cancer

Table of Content

1 Lung Cancer Liquid Biopsy Market Introduction and Overview

1.1 Lung Cancer Liquid Biopsy Definition

1.2 Research Purposes

1.3 Currency Rate

1.4 Report Timeline

1.5 Economic Analysis of Global Regions

1.6 Inflation Analysis

1.7 The Impact of the Russian-Ukrainian War on the Market

2 Market Competition by Manufacturers

2.1 Global Lung Cancer Liquid Biopsy Revenue and Market Share by Manufacturer

2.2 Manufacturers Lung Cancer Liquid Biopsy Production Sites, Area Served, Product Types

2.3 Lung Cancer Liquid Biopsy Market Competitive Situation and Trends

2.3.1 Lung Cancer Liquid Biopsy Market Concentration Rate

2.3.2 Global Top 5 and Top 10 Players Market Share by Revenue in 2023

2.3.3 Mergers & Acquisitions, Expansion

3 Global Lung Cancer Liquid Biopsy Historical Market Analysis by Type

3.1 Market Size Analysis by Types

3.1.4 Global Lung Cancer Liquid Biopsy Market Share by Type 2018 VS 2022

3.2 Global Lung Cancer Liquid Biopsy Revenue and Market Share by Type

4 Global Lung Cancer Liquid Biopsy Historical and Forecast Market Analysis by Application

4.1 Market Size Analysis by Application

4.1.4 Global Lung Cancer Liquid Biopsy Market Share by Application 2018 VS 2022

4.2 Global Lung Cancer Liquid Biopsy Revenue Market Share by Application (2018-2023)

5 Global Market Growth Trends Analysis

5.1 Global Lung Cancer Liquid Biopsy Market Size (2018-2023)

5.2 Lung Cancer Liquid Biopsy Growth Trends Analysis by Regions

5.2.1 Lung Cancer Liquid Biopsy Market Size by Regions: 2018 VS 2023 VS 2029

5.2.2 Lung Cancer Liquid Biopsy Historic Revenue Market Size by Regions (2018-2023)

5.3 North America

5.3.1 North America Lung Cancer Liquid Biopsy Revenue by Countries (2018-2023)

5.3.2 North America SWOT Analysis

5.3.3 United States

5.3.4 Canada

5.4 China

5.4.1 China SWOT Analysis

5.5 Asia Pacific (Excluding China)

5.5.1 Asia Pacific Lung Cancer Liquid Biopsy Revenue by Countries (2018-2023)

5.5.2 Asia Pacific SWOT Analysis

5.5.3 Japan

5.5.4 Korea

5.5.5 Southeast Asia

5.5.6 India

5.5.7 Australia

5.6 EMEA

5.6.1 EMEA Lung Cancer Liquid Biopsy Revenue by Countries (2018-2023)

5.6.2 EMEA SWOT Analysis

5.6.3 Europe

5.6.4 Middle East

5.6.5 Africa

5.7 Latin America

5.7.1 Latin America Lung Cancer Liquid Biopsy Revenue by Countries (2018-2023)

5.7.2 Latin America SWOT Analysis

5.7.3 Brazil

5.7.4 Argentina

5.7.5 Mexico

6 Players Profiles

6.1 Eurofins Scientific (Luxembourg)

6.1.1 Eurofins Scientific (Luxembourg) Company Profile

6.1.2 Lung Cancer Liquid Biopsy Product Overview

6.1.3 Eurofins Scientific (Luxembourg) Lung Cancer Liquid Biopsy Market Performance (2018-2023)

6.1.4 Eurofins Scientific (Luxembourg) Business Overview

6.1.5 SWOT Analysis

6.2 MDxHealth (Belgium)

6.2.1 MDxHealth (Belgium) Company Profile

6.2.2 Lung Cancer Liquid Biopsy Product Overview

6.2.3 MDxHealth (Belgium) Lung Cancer Liquid Biopsy Market Performance (2018-2023)

6.2.4 MDxHealth (Belgium) Business Overview

6.2.5 SWOT Analysis

6.3 CareDx (U.S.)

6.3.1 CareDx (U.S.) Company Profile

6.3.2 Lung Cancer Liquid Biopsy Product Overview

6.3.3 CareDx (U.S.) Lung Cancer Liquid Biopsy Market Performance (2018-2023)

6.3.4 CareDx (U.S.) Business Overview

6.3.5 SWOT Analysis

6.4 Immucor (U.S.)

6.4.1 Immucor (U.S.) Company Profile

6.4.2 Lung Cancer Liquid Biopsy Product Overview

6.4.3 Immucor (U.S.) Lung Cancer Liquid Biopsy Market Performance (2018-2023)

6.4.4 Immucor (U.S.) Business Overview

6.4.5 SWOT Analysis

6.5 Thermo Fisher Scientific Inc. (U.S.)

6.5.1 Thermo Fisher Scientific Inc. (U.S.) Company Profile

6.5.2 Lung Cancer Liquid Biopsy Product Overview

6.5.3 Thermo Fisher Scientific Inc. (U.S.) Lung Cancer Liquid Biopsy Market Performance (2018-2023)

6.5.4 Thermo Fisher Scientific Inc. (U.S.) Business Overview

6.5.5 SWOT Analysis

6.6 Menarini Silicon Biosystems (U.S.)

6.6.1 Menarini Silicon Biosystems (U.S.) Company Profile

6.6.2 Lung Cancer Liquid Biopsy Product Overview

6.6.3 Menarini Silicon Biosystems (U.S.) Lung Cancer Liquid Biopsy Market Performance (2018-2023)

6.6.4 Menarini Silicon Biosystems (U.S.) Business Overview

6.6.5 SWOT Analysis

6.7 QIAGEN (Germany)

6.7.1 QIAGEN (Germany) Company Profile

6.7.2 Lung Cancer Liquid Biopsy Product Overview

6.7.3 QIAGEN (Germany) Lung Cancer Liquid Biopsy Market Performance (2018-2023)

6.7.4 QIAGEN (Germany) Business Overview

6.7.5 SWOT Analysis

6.8 Guardant Health (U.S.)

6.8.1 Guardant Health (U.S.) Company Profile

6.8.2 Lung Cancer Liquid Biopsy Product Overview

6.8.3 Guardant Health (U.S.) Lung Cancer Liquid Biopsy Market Performance (2018-2023)

6.8.4 Guardant Health (U.S.) Business Overview

6.8.5 SWOT Analysis

6.9 Exact Sciences Corporation (U.S.)

6.9.1 Exact Sciences Corporation (U.S.) Company Profile

6.9.2 Lung Cancer Liquid Biopsy Product Overview

6.9.3 Exact Sciences Corporation (U.S.) Lung Cancer Liquid Biopsy Market Performance (2018-2023)

6.9.4 Exact Sciences Corporation (U.S.) Business Overview

6.9.5 SWOT Analysis

6.10 Myriad Genetics, Inc. (U.S.)

6.10.1 Myriad Genetics, Inc. (U.S.) Company Profile

6.10.2 Lung Cancer Liquid Biopsy Product Overview

6.10.3 Myriad Genetics, Inc. (U.S.) Lung Cancer Liquid Biopsy Market Performance (2018-2023)

6.10.4 Myriad Genetics, Inc. (U.S.) Business Overview

6.10.5 SWOT Analysis

6.11 LungLife AI, Inc. (U.S.)

6.11.1 LungLife AI, Inc. (U.S.) Company Profile

6.11.2 Lung Cancer Liquid Biopsy Product Overview

6.11.3 LungLife AI, Inc. (U.S.) Lung Cancer Liquid Biopsy Market Performance (2018-2023)

6.11.4 LungLife AI, Inc. (U.S.) Business Overview

6.11.5 SWOT Analysis

6.12 Bio-Rad Laboratories, Inc. (U.S.)

6.12.1 Bio-Rad Laboratories, Inc. (U.S.) Company Profile

6.12.2 Lung Cancer Liquid Biopsy Product Overview

6.12.3 Bio-Rad Laboratories, Inc. (U.S.) Lung Cancer Liquid Biopsy Market Performance (2018-2023)

6.12.4 Bio-Rad Laboratories, Inc. (U.S.) Business Overview

6.12.5 SWOT Analysis

6.13 Agilent Technologies Inc. (U.S.)

6.13.1 Agilent Technologies Inc. (U.S.) Company Profile

6.13.2 Lung Cancer Liquid Biopsy Product Overview

6.13.3 Agilent Technologies Inc. (U.S.) Lung Cancer Liquid Biopsy Market Performance (2018-2023)

6.13.4 Agilent Technologies Inc. (U.S.) Business Overview

6.13.5 SWOT Analysis

6.14 Natera, Inc. (U.S.)

6.14.1 Natera, Inc. (U.S.) Company Profile

6.14.2 Lung Cancer Liquid Biopsy Product Overview

6.14.3 Natera, Inc. (U.S.) Lung Cancer Liquid Biopsy Market Performance (2018-2023)

6.14.4 Natera, Inc. (U.S.) Business Overview

6.14.5 SWOT Analysis

6.15 CARDIFF ONCOLOGY, INC. (U.S.)

6.15.1 CARDIFF ONCOLOGY, INC. (U.S.) Company Profile

6.15.2 Lung Cancer Liquid Biopsy Product Overview

6.15.3 CARDIFF ONCOLOGY, INC. (U.S.) Lung Cancer Liquid Biopsy Market Performance (2018-2023)

6.15.4 CARDIFF ONCOLOGY, INC. (U.S.) Business Overview

6.15.5 SWOT Analysis

6.16 Exosome Diagnostics Inc. (U.S.)

6.16.1 Exosome Diagnostics Inc. (U.S.) Company Profile

6.16.2 Lung Cancer Liquid Biopsy Product Overview

6.16.3 Exosome Diagnostics Inc. (U.S.) Lung Cancer Liquid Biopsy Market Performance (2018-2023)

6.16.4 Exosome Diagnostics Inc. (U.S.) Business Overview

6.16.5 SWOT Analysis

6.17 Illumina, Inc. (U.S.)

6.17.1 Illumina, Inc. (U.S.) Company Profile

6.17.2 Lung Cancer Liquid Biopsy Product Overview

6.17.3 Illumina, Inc. (U.S.) Lung Cancer Liquid Biopsy Market Performance (2018-2023)

6.17.4 Illumina, Inc. (U.S.) Business Overview

6.17.5 SWOT Analysis

6.18 Genomic Health Inc. (U.S.)

6.18.1 Genomic Health Inc. (U.S.) Company Profile

6.18.2 Lung Cancer Liquid Biopsy Product Overview

6.18.3 Genomic Health Inc. (U.S.) Lung Cancer Liquid Biopsy Market Performance (2018-2023)

6.18.4 Genomic Health Inc. (U.S.) Business Overview

6.18.5 SWOT Analysis

6.19 F. Hoffmann-La Roche Ltd (Switzerland)

6.19.1 F. Hoffmann-La Roche Ltd (Switzerland) Company Profile

6.19.2 Lung Cancer Liquid Biopsy Product Overview

6.19.3 F. Hoffmann-La Roche Ltd (Switzerland) Lung Cancer Liquid Biopsy Market Performance (2018-2023)

6.19.4 F. Hoffmann-La Roche Ltd (Switzerland) Business Overview

6.19.5 SWOT Analysis

7 Lung Cancer Liquid Biopsy Business Cost Analysis

7.1 Labor Cost Analysis

7.2 Proportion of Manufacturing Cost Structure

7.3 Lung Cancer Liquid Biopsy Industrial Chain Analysis

8 Lung Cancer Liquid Biopsy Industry Dynamic Analysis

8.1 Lung Cancer Liquid Biopsy Market Trends Analysis

8.2 Lung Cancer Liquid Biopsy Market Drivers Analysis

8.3 Lung Cancer Liquid Biopsy Market Challenges Analysis

8.4 Lung Cancer Liquid Biopsy Market Restraints Analysis

9 Global Lung Cancer Liquid Biopsy Forecast Market Analysis by Type & Application

9.1 Global Lung Cancer Liquid Biopsy Revenue Market Forecast by Type (2023-2029)

9.2 Lung Cancer Liquid Biopsy Revenue Market Forecast by Application (2023-2029)

10 Global Lung Cancer Liquid Biopsy Forecast Market Analysis by Region

10.1 Lung Cancer Liquid Biopsy Revenue Market Forecast by Region (2023-2029)

10.2 North America Lung Cancer Liquid Biopsy Forecast Market Analysis

10.3 EMEA Lung Cancer Liquid Biopsy Forecast Market Analysis

10.4 China Lung Cancer Liquid Biopsy Forecast Market Analysis

10.5 Asia-Pacific Lung Cancer Liquid Biopsy Forecast Market Analysis

10.6 Latin America Lung Cancer Liquid Biopsy Forecast Market Analysis

11 Research Findings and Conclusion

List of Tables and Figures

Figure Lung Cancer Liquid Biopsy Picture

Table Product Definition of Lung Cancer Liquid Biopsy

Table Economic Analysis of Global Regions

Table Inflation Analysis

Table The Impact of the Russian-Ukrainian War on the Market

Table Global Lung Cancer Liquid Biopsy Revenue ($) by Manufacturer (2018-2023)

Table Global Lung Cancer Liquid Biopsy Revenue Market Share by Manufacturer (2018-2023)

Figure Global Lung Cancer Liquid Biopsy Revenue Market Share by Manufacturer in 2023

Table Manufacturers Lung Cancer Liquid Biopsy Production Sites, Area Served, Product Types

Table Lung Cancer Liquid Biopsy Market Concentration Rate

Figure Global Top 5 and Top 10 Players Market Share by Revenue in 2023

Table Mergers & Acquisitions, Expansion Plans

Table Global Lung Cancer Liquid Biopsy Market Size by Type (2023 VS 2029)

Figure Global Lung Cancer Liquid Biopsy Market Share by Type 2018 VS 2022

Table Global Lung Cancer Liquid Biopsy Revenue and Market Size by Type (2018-2023)

Table Global Lung Cancer Liquid Biopsy Revenue and Market Share by Type (2018-2023)

Table Global Lung Cancer Liquid Biopsy Market Size by Application (2023 VS 2029)

Figure Global Lung Cancer Liquid Biopsy Market Share by Application 2018 VS 2022

Table Global Lung Cancer Liquid Biopsy Revenue Market Size by Application (2018-2023)

Table Global Lung Cancer Liquid Biopsy Revenue Market Share by Application (2018-2023)

Figure Global Lung Cancer Liquid Biopsy Revenue Market Size (2018-2023)

Table Lung Cancer Liquid Biopsy Market Size by Regions: 2018 VS 2023 VS 2029

Table Lung Cancer Liquid Biopsy Historic Revenue Market Size by Regions (2018-2023)

Table Lung Cancer Liquid Biopsy Historic Revenue Market Share by Regions (2018-2023)

Figure North America Lung Cancer Liquid Biopsy Revenue and Growth (2018-2023)

Table North America Lung Cancer Liquid Biopsy Revenue by Countries (2018-2023)

Table North America Lung Cancer Liquid Biopsy Revenue Market Share by Countries (2018-2023)

Table North America SWOT Analysis

Figure United States Lung Cancer Liquid Biopsy Revenue and Growth (2018-2023)

Figure Canada Lung Cancer Liquid Biopsy Revenue and Growth (2018-2023)

Table China SWOT Analysis

Figure China Lung Cancer Liquid Biopsy Revenue and Growth (2018-2023)

Figure Asia Pacific Lung Cancer Liquid Biopsy Revenue and Growth (2018-2023)

Table Asia-Pacific Lung Cancer Liquid Biopsy Revenue by Countries (2018-2023)

Table Asia-Pacific Lung Cancer Liquid Biopsy Revenue Market Share by Countries (2018-2023)

Table Asia Pacific SWOT Analysis

Figure Japan Lung Cancer Liquid Biopsy Revenue and Growth (2018-2023)

Figure Korea Lung Cancer Liquid Biopsy Revenue and Growth (2018-2023)

Figure Southeast Asia Lung Cancer Liquid Biopsy Revenue and Growth (2018-2023)

Figure India Lung Cancer Liquid Biopsy Revenue and Growth (2018-2023)

Figure Australia Lung Cancer Liquid Biopsy Revenue and Growth (2018-2023)

Figure EMEA Lung Cancer Liquid Biopsy Revenue and Growth (2018-2023)

Table EMEA Lung Cancer Liquid Biopsy Revenue by Countries (2018-2023)

Table EMEA Lung Cancer Liquid Biopsy Revenue Market Share by Countries (2018-2023)

Table EMEA SWOT Analysis

Figure Europe Lung Cancer Liquid Biopsy Revenue and Growth (2018-2023)

Figure Germany Lung Cancer Liquid Biopsy Revenue and Growth (2018-2029)

Figure France Lung Cancer Liquid Biopsy Revenue and Growth (2018-2029)

Figure UK Lung Cancer Liquid Biopsy Revenue and Growth (2018-2029)

Figure Italy Lung Cancer Liquid Biopsy Revenue and Growth (2018-2029)

Figure Russia Lung Cancer Liquid Biopsy Revenue and Growth (2018-2029)

Figure Nordic Lung Cancer Liquid Biopsy Revenue and Growth (2018-2029)

Figure Middle East Lung Cancer Liquid Biopsy Revenue and Growth (2018-2023)

Figure Africa Lung Cancer Liquid Biopsy Revenue and Growth (2018-2023)

Figure Latin America Lung Cancer Liquid Biopsy Revenue and Growth (2018-2023)

Table Latin America Lung Cancer Liquid Biopsy Revenue by Countries (2018-2023)

Table Latin America Lung Cancer Liquid Biopsy Revenue Market Share by Countries (2018-2023)

Table Latin America SWOT Analysis

Figure Brazil Lung Cancer Liquid Biopsy Revenue and Growth (2018-2023)

Figure Argentina Lung Cancer Liquid Biopsy Revenue and Growth (2018-2023)

Figure Mexico Lung Cancer Liquid Biopsy Revenue and Growth (2018-2023)

Table Eurofins Scientific (Luxembourg) Profile

Table Product Overview

Table Eurofins Scientific (Luxembourg) Lung Cancer Liquid Biopsy Revenue, Gross and Gross Margin (2018-2023)

Figure Eurofins Scientific (Luxembourg) Revenue and Growth Rate

Figure Eurofins Scientific (Luxembourg) Revenue Market Share 2017-2022

Table Business Overview

Table SWOT Analysis

Table MDxHealth (Belgium) Profile

Table Product Overview

Table MDxHealth (Belgium) Lung Cancer Liquid Biopsy Revenue, Gross and Gross Margin (2018-2023)

Figure MDxHealth (Belgium) Revenue and Growth Rate

Figure MDxHealth (Belgium) Revenue Market Share 2017-2022

Table Business Overview

Table SWOT Analysis

Table CareDx (U.S.) Profile

Table Product Overview

Table CareDx (U.S.) Lung Cancer Liquid Biopsy Revenue, Gross and Gross Margin (2018-2023)

Figure CareDx (U.S.) Revenue and Growth Rate

Figure CareDx (U.S.) Revenue Market Share 2017-2022

Table Business Overview

Table SWOT Analysis

Table Immucor (U.S.) Profile

Table Product Overview

Table Immucor (U.S.) Lung Cancer Liquid Biopsy Revenue, Gross and Gross Margin (2018-2023)

Figure Immucor (U.S.) Revenue and Growth Rate

Figure Immucor (U.S.) Revenue Market Share 2017-2022

Table Business Overview

Table SWOT Analysis

Table Thermo Fisher Scientific Inc. (U.S.) Profile

Table Product Overview

Table Thermo Fisher Scientific Inc. (U.S.) Lung Cancer Liquid Biopsy Revenue, Gross and Gross Margin (2018-2023)

Figure Thermo Fisher Scientific Inc. (U.S.) Revenue and Growth Rate

Figure Thermo Fisher Scientific Inc. (U.S.) Revenue Market Share 2017-2022

Table Business Overview

Table SWOT Analysis

Table Menarini Silicon Biosystems (U.S.) Profile

Table Product Overview

Table Menarini Silicon Biosystems (U.S.) Lung Cancer Liquid Biopsy Revenue, Gross and Gross Margin (2018-2023)

Figure Menarini Silicon Biosystems (U.S.) Revenue and Growth Rate

Figure Menarini Silicon Biosystems (U.S.) Revenue Market Share 2017-2022

Table Business Overview

Table SWOT Analysis

Table QIAGEN (Germany) Profile

Table Product Overview

Table QIAGEN (Germany) Lung Cancer Liquid Biopsy Revenue, Gross and Gross Margin (2018-2023)

Figure QIAGEN (Germany) Revenue and Growth Rate

Figure QIAGEN (Germany) Revenue Market Share 2017-2022

Table Business Overview

Table SWOT Analysis

Table Guardant Health (U.S.) Profile

Table Product Overview

Table Guardant Health (U.S.) Lung Cancer Liquid Biopsy Revenue, Gross and Gross Margin (2018-2023)

Figure Guardant Health (U.S.) Revenue and Growth Rate

Figure Guardant Health (U.S.) Revenue Market Share 2017-2022

Table Business Overview

Table SWOT Analysis

Table Exact Sciences Corporation (U.S.) Profile

Table Product Overview

Table Exact Sciences Corporation (U.S.) Lung Cancer Liquid Biopsy Revenue, Gross and Gross Margin (2018-2023)

Figure Exact Sciences Corporation (U.S.) Revenue and Growth Rate

Figure Exact Sciences Corporation (U.S.) Revenue Market Share 2017-2022

Table Business Overview

Table SWOT Analysis

Table Myriad Genetics, Inc. (U.S.) Profile

Table Product Overview

Table Myriad Genetics, Inc. (U.S.) Lung Cancer Liquid Biopsy Revenue, Gross and Gross Margin (2018-2023)

Figure Myriad Genetics, Inc. (U.S.) Revenue and Growth Rate

Figure Myriad Genetics, Inc. (U.S.) Revenue Market Share 2017-2022

Table Business Overview

Table SWOT Analysis

Table LungLife AI, Inc. (U.S.) Profile

Table Product Overview

Table LungLife AI, Inc. (U.S.) Lung Cancer Liquid Biopsy Revenue, Gross and Gross Margin (2018-2023)

Figure LungLife AI, Inc. (U.S.) Revenue and Growth Rate

Figure LungLife AI, Inc. (U.S.) Revenue Market Share 2017-2022

Table Business Overview

Table SWOT Analysis

Table Bio-Rad Laboratories, Inc. (U.S.) Profile

Table Product Overview

Table Bio-Rad Laboratories, Inc. (U.S.) Lung Cancer Liquid Biopsy Revenue, Gross and Gross Margin (2018-2023)

Figure Bio-Rad Laboratories, Inc. (U.S.) Revenue and Growth Rate

Figure Bio-Rad Laboratories, Inc. (U.S.) Revenue Market Share 2017-2022

Table Business Overview

Table SWOT Analysis

Table Agilent Technologies Inc. (U.S.) Profile

Table Product Overview

Table Agilent Technologies Inc. (U.S.) Lung Cancer Liquid Biopsy Revenue, Gross and Gross Margin (2018-2023)

Figure Agilent Technologies Inc. (U.S.) Revenue and Growth Rate

Figure Agilent Technologies Inc. (U.S.) Revenue Market Share 2017-2022

Table Business Overview

Table SWOT Analysis

Table Natera, Inc. (U.S.) Profile

Table Product Overview

Table Natera, Inc. (U.S.) Lung Cancer Liquid Biopsy Revenue, Gross and Gross Margin (2018-2023)

Figure Natera, Inc. (U.S.) Revenue and Growth Rate

Figure Natera, Inc. (U.S.) Revenue Market Share 2017-2022

Table Business Overview

Table SWOT Analysis

Table CARDIFF ONCOLOGY, INC. (U.S.) Profile

Table Product Overview

Table CARDIFF ONCOLOGY, INC. (U.S.) Lung Cancer Liquid Biopsy Revenue, Gross and Gross Margin (2018-2023)

Figure CARDIFF ONCOLOGY, INC. (U.S.) Revenue and Growth Rate

Figure CARDIFF ONCOLOGY, INC. (U.S.) Revenue Market Share 2017-2022

Table Business Overview

Table SWOT Analysis

Table Exosome Diagnostics Inc. (U.S.) Profile

Table Product Overview

Table Exosome Diagnostics Inc. (U.S.) Lung Cancer Liquid Biopsy Revenue, Gross and Gross Margin (2018-2023)

Figure Exosome Diagnostics Inc. (U.S.) Revenue and Growth Rate

Figure Exosome Diagnostics Inc. (U.S.) Revenue Market Share 2017-2022

Table Business Overview

Table SWOT Analysis

Table Illumina, Inc. (U.S.) Profile

Table Product Overview

Table Illumina, Inc. (U.S.) Lung Cancer Liquid Biopsy Revenue, Gross and Gross Margin (2018-2023)

Figure Illumina, Inc. (U.S.) Revenue and Growth Rate

Figure Illumina, Inc. (U.S.) Revenue Market Share 2017-2022

Table Business Overview

Table SWOT Analysis

Table Genomic Health Inc. (U.S.) Profile

Table Product Overview

Table Genomic Health Inc. (U.S.) Lung Cancer Liquid Biopsy Revenue, Gross and Gross Margin (2018-2023)

Figure Genomic Health Inc. (U.S.) Revenue and Growth Rate

Figure Genomic Health Inc. (U.S.) Revenue Market Share 2017-2022

Table Business Overview

Table SWOT Analysis

Table F. Hoffmann-La Roche Ltd (Switzerland) Profile

Table Product Overview

Table F. Hoffmann-La Roche Ltd (Switzerland) Lung Cancer Liquid Biopsy Revenue, Gross and Gross Margin (2018-2023)

Figure F. Hoffmann-La Roche Ltd (Switzerland) Revenue and Growth Rate

Figure F. Hoffmann-La Roche Ltd (Switzerland) Revenue Market Share 2017-2022

Table Business Overview

Table SWOT Analysis

Table Labor Cost Analysis

Figure Proportion of Manufacturing Cost Structure

Figure Lung Cancer Liquid Biopsy Industrial Chain Analysis

Table Market Trends Analysis

Table Market Drivers Analysis

Table Market Challenges Analysis

Table Market Restraints Analysis

Table Global Lung Cancer Liquid Biopsy Revenue Market Size Forecast by Type (2023-2029)

Table Global Lung Cancer Liquid Biopsy Revenue Market Share Forecast by Type (2023-2029)

Table Global Lung Cancer Liquid Biopsy Revenue Market Size by Application (2023-2029)

Table Global Lung Cancer Liquid Biopsy Revenue Market Share by Application (2023-2029)

Table Global Lung Cancer Liquid Biopsy Revenue Market Size by Region (2023-2029)

Table Global Lung Cancer Liquid Biopsy Revenue Market Share by Region (2023-2029)

Figure North America Lung Cancer Liquid Biopsy Forecast Revenue and Growth 2023-2029

Figure EMEA Lung Cancer Liquid Biopsy Forecast Revenue and Growth 2023-2029

Figure China Lung Cancer Liquid Biopsy Forecast Revenue and Growth 2023-2029

Figure Asia-Pacific Lung Cancer Liquid Biopsy Forecast Revenue and Growth 2023-2029

Figure Latin America Lung Cancer Liquid Biopsy Forecast Revenue and Growth 2023-2029

Methodology/Research Approach

This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.

Research Programs/Design

Historical Data (2015-2019)	Industry Trends Competitive Landscape By Company Expansion Mergers and Acquisitions Market Segment by Type by Application By Regions/ Geography	Value Status and Outlook Value for Major Players Market Share Growth Rate Present Situation Analysis Value Market Share Growth Rate Present Situation Analysis
Influencing Factors	Market Environment Government Policy Technological Changes Market Risks	Market Drivers Growing Demand of Downstream Reduction in Cost
Market Forecast (2021-2026)	Overall Size by Type by Application By Regions/Geography	Key Data (Value) Market Share Growth Rate CAGR (2021-2026)

Market Size Estimation

Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).

The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.

Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.

All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report

The following figure shows an illustrative representation of the overall market size estimation process used for this study.

Market Breakdown and Data Triangulation

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.

Data Source

Secondary Sources

Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.

Market Size	Segmental value Geographic Penetration Product Adoption Rate for Different market	Journals, Websites, and Press Releases Annual Reports and SEC Filings Company Websites and Press Releases Public and Paid Databases Market Intellix Data Repository
Market Position of Top Company	Product Financials Geographic value Mix Total Company value Business/Segmental value Mix
Qualitative Analysis	Influence Factors Market Potential Market Risks and Opportunities Industry Trends Geographical Features Government Policies	Company Websites and Press Releases Public and Paid Databases Annual Reports Industry Associations Market Intellix Data Repository

Primary Sources

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.

Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.

Key Executives Interviewed

Key Data Information from Primary Sources

Primary Sources	Parameters	Key Data
Market Segments(by Application, by Type)	Value by Type Status and Forecast Value by Application Value by Regions, Status and Forecast (2021-2026)	Value Market Share by Type Value Growth Rate by Type Value by Application Percentage and Growth Rate by Application Value Growth Rate and Market Share by Regions Market Size Status and Forecast (2021-2026)
Total Market	Overall Size, Status and Forecast	Market Size Status and Forecast (2021-2026)